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Abstract
BACKGROUND: Dry socket is the most common post-operative complication following a dental extraction and one 
of the most studied complications in dentistry. Many researchers have attempted to find a successful method for its 
primary prevention. However, this area remains controversial as no single method has gained universal acceptance. 
Therefore, secondary prevention of this case is still needed to prevent the continuing effects of dry sockets and other 
complications resulting from inadequate dry socket treatment. One of the most common treatments of dry socket is 
a combination of butyl aminobenzoate, eugenol, and iodoform. The presence of this medicament in a healing socket 
also has been shown to cause a foreign body reaction, delayed healing, and prolonged pain.
AIM: The objective of the study was to compare the treatment results of dressing with a combination of butyl 
aminobenzoate, eugenol, and iodoform and other treatments for dry socket regarding the result of pain’s relief and 
healing of sockets.
METHODS: Searches were conducted in the following electronic databases: PubMed, ProQuest, and EBSCO. The 
inclusion criteria were randomized controlled trial with a minimum of 10 patients, published from 2009 to 2019, and 
written in English. The exclusion criteria were case reports and non-human studies.
RESULTS: Ten articles were found in an initial search, of which six were selected for a systematic review. Alternative 
treatment identified included zinc oxide eugenol (ZOE), a combination of polymyxin B sulfate, tyrothricin, neomycin 
sulfate, tetracaine hydrochloride, freeze-dried pledget containing acemannan hydrogel, plasma rich in growth factors, 
and low-level laser therapy, Er:Cr:YSGG, and laser diodes.
CONCLUSION: All treatments included in the review have the aim to relief the patient’s pain. Given the heterogeneity 
of interventions and the type of measurement scale, the results are difficult to compare. The combination of butyl 
aminobenzoate, eugenol, and iodoform is superior compared to ZOE for pain relief and socket healing. For socket 
healing and pain relief from the 2nd day after the extraction, it appears that several alternative treatments are superior 
to the combination of butyl aminobenzoate, eugenol, and iodoform.
Introduction
Dry socket is a post-tooth extraction 
complication that most commonly occurs [1] and is 
most widely studied [2]. Some other terminologies of 
dry socket include alveolar osteitis, fibrinolytic alveolitis, 
alveolitis sicca dolorosa, post-operative alveolitis, 
alveolalgia, septic socket, necrotic socket, localized 
osteomyelitis, delayed extraction wound healing, and 
localized osteitis. Crawford began to use the term 
“dry socket” in 1896 [3]. The incidence of dry socket 
in post-simple tooth extraction and surgical tooth 
extraction varies greatly. It ranges from 1% to 70% and 
more frequently occurs in the post-lower third molar 
extraction [3], [4].
The primary etiology of dry socket is an 
increase in local fibrinolytic activity. The increase can 
cause loss of intra-alveolar blood clots after tooth 
extraction [5]. The fibrinolysis is the result of activation 
of the plasminogen pathway, which can be achieved 
through the substance of a direct (physiological) or 
indirect (non-physiological) activator. The activators 
are released immediately after trauma to the alveolar 
bone cells and are not directly secreted by bacteria [6]. 
However, the exact etiology of dry sockets explained 
above is not yet well understood [7], [8].
Many risk factors are associated with dry 
sockets, such as extraction trauma and extraction 
difficulties, mandibular third molar extraction, systemic 
disease, bacterial infection, excessive irrigation or 
curettage, local anesthesia with vasoconstrictors, and 
bone or root fragments remaining in socket [6]. Patients 
with dry sockets usually experience persistent pain 
around the socket and the location of the operation 
after tooth extraction. These symptoms usually appear 
two to four quickly disappear even after consuming 
analgesics and often halitosis [9]. Concerning these 
signs and symptoms, the primary purpose of dry socket 
treatment is to relieve pain and stimulate the healing 
process of open bone, especially by palliative care.
Since the dry socket is the most common 
complication at post-tooth extraction, many researchers 
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work to find a method for primary prevention of dry socket. 
However, it remains controversial because there is no single 
method that can be universally accepted [6]. Therefore, 
secondary prevention of this case is still needed to prevent 
the continued effects of dry socket (a decrease in quality of 
life due to pain, discomfort in the mouth, and halitosis) and 
other complications resulting from inadequate dry socket 
treatments such as trigeminal neuralgia [10], neuritis [11], 
and foreign body reactions [12].
Dry socket treatments are divided into two 
groups, namely, undressing and dressing. The use of 
dressings for dry socket treatment is still controversial 
because there have been no studies explicitly identifying 
the assessment toward the occurrence of potential side 
effects and tissue damage arising from its placement 
into the socket [9].
One of the dressings that have been widely 
used in dry socket treatment and are often mentioned 
in the literature is an ingredient with a combination of 
butyl para-aminobenzoate and iodoform. Literature 
states that the presence of the dressing material in the 
socket causes foreign body reaction, delayed healing, 
and prolonged pain (up to 14 days) [13].
This study aims to compare the result of dry 
socket treatment using a combination of butyl para-
aminobenzoate and iodoform and other treatments for a 
dry socket to relieve pain and stimulate socket healing.
Materials and Methods
This systematic study was constructed by 
following the guidelines for preferred reporting items for 
systematic reviews and meta-analysis [14]. The patient, 
intervention, comparison, outcome, and study (PICOS) 
framework (population, intervention, control, results, 
and study design) was designed to identify studies and 
use their elements as the main selection criteria [15].
Eligibility criteria
This study aims to conduct a literature review 
comparing the result of dry socket treatment using a 
combination of butyl para-aminobenzoate and iodoform 
to other dry socket treatments. The concept of was 
arranged as follows:
•	 P (patient): Patients with dry socket after tooth 
extraction
•	 I (intervention): Dressing with ingredients 
containing butyl para-aminobenzoate and 
iodoform
•	 C (comparison ): Other dry socket treatments
•	 O (outcome): Reduction of pain and healing
•	 S (study): Clinical trial with or without a placebo 
comparison.
Inclusion criteria included clinical research with 
a minimum of 10 patients as respondents published 
in English from 2009 to 2019. Meanwhile, exclusion 
criteria included case reports and systematic reviews. 
The characteristics of the patients in this study were 
all ages, both men and women who experienced dry 
socket after tooth extraction, either a simple extraction 
or surgical extraction.
Information sources 
The search was conducted in the electronic 
databases, such as PubMed (including Medline), 
Google Scholar, and Clinical Key.
Search strategy
Electronic search in the PubMed database, 
Google Scholar, and Clinical Key was carried out using 
medical terms as the subject title and search algorithms 
with key terms for the title and abstract, for instance, 
“alvogyl” or “butyl para-aminobenzoate + iodoform” and 
“dry socket” or “fibrinolytic alveolitis” or “sicca dolorosa 
alveolitis” or “postoperative alveolitis” or “alveolalgia” 
or “septic socket” or “necrotic socket” or “localized 
osteomyelitis” or “localized osteitis” or “delayed wound 
healing of extraction.”
Study selection
196 records identified
through database searching
(Google Scholar = 100)
(PubMed = 70)
(Clinical Key = 26)
Records excluded by abstract
selection : 
Google scholar : 
8 article excluded because  it,s
not in english
1 article excluded because the
number of research subjects less
than 10
31 article excluded because  it’s
not about dry socket
19 article excluded because  it’s
not about dry socket’s treatment
16 article excluded because
review
PubMed : 
43 article excluded because  it’s
not about dry socket
16 article excluded because  it’s
not about dry socket’s treatment
Clinical Key : 
13 article excluded because  it’s
not about dry socket
4 article excluded because  it’s
not about dry socket’s treatment
175 Records after
duplication selection 
23 fulltext articles assessed
for eligibility
(Google Scholar = 7)
(PubMed = 11)
(Clinical Key = 5)
Studies included in the
systematic review (10)
Records excluded by
abstract selection (13) :
Google scholar : 
5 article excluded because
does not compare with the
combination of butyl para
aminobenzoate + iodoform
PubMed :
3 the article was excluded
because about  primary
prevention for dry sockets
3 article excluded because
does not compare with the
combination of butyl para
aminobenzoate + iodoform
Clinical Key : 
2 article excluded because
does not compare with the
combination of butyl para
aminobenzoate + iodoform
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Outcomes and prioritization
The outcome reviewed in this study was pain 
reduction and socket healing. The prioritized outcome 
was pain reduction because the main disturbing 
symptom to the dry socket is pain.
Risk of bias in individual studies
The risk of bias was assessed based on the 
guidelines of the Cochrane Collaboration [16], [17]. The 
guidelines are such as sequence generation, allocation 
concealment, blinding of the participant, blinding of care 
provider, the incomplete outcome of data addressed, 
and free from funding sources of bias.
Results
In the result of the initial search, it was 
obtained 196 articles. On the process of duplication 
reduction, 175 articles were obtained. At the abstract 
assessment stage, 152 articles were excluded because 
they were irrelevant. Full-text assessment was carried 
out on 23 articles, and then, 10 articles were excluded 
because they did not compare dry socket treatment 
with a combination of butyl para-aminobenzoate and 
iodoform. The other three articles were also excluded 
because medicament material was used to prevent 
dry socket. Therefore, 10 articles were reviewed in this 
systematic study.
Alternative treatments found were such as 
zinc oxide eugenol (ZOE), chlorhexidine digluconate 
gel, hyaluronic acid with or without aminocaproic, 
a combination of polymyxin B sulfate, tyrothricin, 
neomycin sulfate, tetracaine hydrochloride, freeze-dried 
pledget containing acemannan hydrogel, plasma rich 
in growth factors (PRGF), and low-level laser therapy, 
Er:Cr:YSGG, and laser diodes. Some ingredients, such 
as ZOE and chlorhexidine digluconate gel, were found 
in several journals.
About the review conduction, the majority of 
tests had a high risk of bias. All articles are unclear on the 
sequence generation process. There was 1 article [18] 
which had high risk in allocation concealment because 
randomization was carried out by research staff, and 
the other two articles [19], [20] had a low risk because 
it used randomization with tables as well as systematic 
random sampling methods. No articles were explaining 
how to conduct participant blinding, and only two articles 
carried out blinding of the clinical examination [18], [20]. 
Furthermore, one article explained about the training 
provided to patients on how to measure visual analog 
scale (VAS) and calibrating clinical examinations 
performed by dentists with P score = 0.78 [18].
On the other hand, there was one article stating 
that the research obtained funding sources that had a 
potential of risk of bias in the result of the research [18] 
and that the article was included in the category of having 
a high risk of bias. In terms of the financial aspect, two 
articles mentioned funding sources and thank you note 
that had no risk of bias [19], [20] while the other article 
mentioned that it did not receive financial support [20]. 
In addition, five articles did not explain financial sources 
[16], [17], [18], [19], [20] (Table 1).
Dry socket diagnosis
The diagnosis was explained by seven articles 
[7], [8], [10], [11], [18], [19], [20]. All of them used 
pain as a primary indication for the diagnosis of a dry 
socket. There were three articles [19], [20]  referring to 
the definition of Blum, 2002 [9], as the diagnosis, for 
instance, pain and damaged blood clot in the socket, 
along with or without halitosis. The other indication used 
for the diagnosis was the open bone on the socket.
Stage before application
Irrigation with sterile saline was applied to 
all groups in the articles reviewed. All irrigations were 
carried out under local infiltration anesthesia. There 
were two articles [17], [19] stating to avoid curettage in 
the socket while another article [20] conducted curates 
after anesthesia. Furthermore, medication application 
varied greatly. One of the articles [18] explained that it 
did not give antibiotics to all study subjects, while the 
other two articles [16], [20] did not include subjects 
who received antibiotics after extraction. Article [17] 
mentioned giving amoxicillin and metronidazole as 
antibiotics to all study subjects. Another article [18] gave 
tablets containing diclofenac sodium and paracetamol 
to all study subjects, while the other article gave 
ibuprofen.
Table 1: Risk of bias
Study Sequence generation Allocation concealment Blinding of participant Blinding of care provider Incomplete outcome data addressed Free from sources funding bias
20 Unclear High risk High risk High risk Low risk High risk
21 Unclear Low risk High risk High risk High risk Low risk
22 Unclear Unclear High risk High risk High risk Unclear
23 Unclear Unclear High risk High risk High risk Low risk
24 Unclear Low risk Unclear Low risk High risk Unclear
25 Unclear Unclear Unclear Unclear High risk Low risk
26 Unclear Unclear Unclear Unclear High risk Unclear
7 Unclear Unclear Unclear Unclear High risk Unclear
28 Unclear Unclear Unclear Unclear High risk Unclear
29 Unclear Unclear Unclear Unclear High risk Unclear
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Observation time
The observation time varied, as shown in 
Table 2:
Table 2: Observation time
No. of article Observation time
16 On the 3rd day (+ - 1 day) and the 7th day (+ -1 day)
17 Patients were asked to note pain in the morning, after 6 h and after  
12 h, for 3 days
18 The pain was checked every morning for 1 week after the initial 
debridement using visual analog scale. Clinical examination of signs and 
symptoms is examined at the time of diagnosis, 3 days after diagnosis, 
and 7 days after diagnosis
19 The pain was examined on the 3rd, 4th, and 5th day. Healing was 
examined on the 4th, 7th, 10th, and14th day
20 Pain and healing were examined 5 min, 30 min, 1 h, 1st, 2nd, 3rd, 5th, 7th, 
and 10th days after medicament application
21 Pain and healing were examined on the 3rd, 5th, 7th, and 10th day
The measured outcome
1. Pain
Pain is a significant symptom of dry socket 
pathology. Therefore, all articles analyzed the pain 
reduction and compared to other various treatment 
alternatives. In terms of assessing pain intensity, 
VAS was used to identify patients’ intensity of pain, 
with a range of scores between 0 (no pain) and 10 
(unbearable massive pain) [15], [16], [19], [20]. Two 
articles [18], [20] used VAS by asking the patients 
the intensity of pain, with a score between 0 and 
10 [19], [20], and categorized them into three criteria, 
such as mild (the VAS score 1–4), average (the VAS 
score 5–-7), and high (the VAS score 8–10). One 
article [19] used the criteria of the dose of analgesic 
needed, namely, diclofenac sodium, with a score of 0 
(no pain and no analgesia are needed); 1–3 (mild pain 
and when one tablet of 50 mg of diclofenac sodium 
per day is consumed); 4–6 (moderate pain and when 
two tablets of 50 mg of diclofenac sodium per day are 
consumed); and 7–10 (severe pain and when more 
than two tablets of 50 mg of diclofenac sodium per day 
are consumed). Besides that, another article [13] used 
the Wong-Baker VAS.
2. Healing
The alveolar mucosa is one of the most 
commonly used indications to assess dry socket healing. 
It is more objective than pain reduction. However, four 
articles [12], [13], [17], [20] reviewed did not conduct an 
assessment of the healing process.
Various indicators of healing used in the article 
are such as: The exposed alveolar bone, halitosis, 
and dysgeusia [18]; halitosis, empty sockets, redness 
around the socket, and mouth discomfort [20]; open 
bones, no granulation tissue, and tenderness [18]; 
empty sockets, open bones, and redness around 
the socket [18]; sockets are covered by granulation 
tissue [20]; the spread of pain, swollen lymphonodi, 
redness, and halitosis [19].
One of the articles [10] added measured 
outcomes; for example, the amount of dressing 
required until the socket is cured. The other outcome 
was the complication of a dry socket that was the slow 
healing process, abscesses, osteomyelitis, infection, 
and reactions due to the foreign body. Meanwhile, the 
other article [18] added measured outcome, namely, 
sensitivity to gentle probing on the socket.
Discussion
Pain reduction
The observation time varied considerably 
among the articles reviewed. Article [19] using VAS 
indicator, which differs from the other. The indicator 
used the amount of diclofenac sodium consumed by 
the patient to relieve pain. Moreover, the comparison 
between a combination of butyl para-aminobenzoate 
and iodoform and other treatments also varied.
Compared to the PGRF, there is no significant 
difference in the reduction of pain at all observation times. 
Similar results were identified when the combination of 
butyl para-aminobenzoate and iodoform is compared to 
freeze-dried pledget containing acemannan hydrogel 
and the radiation of Er:Cr:YSGG.
There is a study in one article [18] with the 
most detailed observation time, which is gradually 
examined at the 5th min, 30th min, 1st h, 1st day, 2nd day, 
3rd day, 5th day, 7th day, and 10th day after medicament 
application. Therefore, it can be seen that the average 
of the fastest time to start a pain reduction using the 
combination between butyl para-aminobenzoate 
and iodoform is at the 7.35th min. The time record is 
faster than other treatments, which are at the 17.23rd 
min for the combination between polymyxin B sulfate, 
tyrothricin, neomycin sulfate, tetracaine hydrochloride, 
and at the 25.02nd min for ZOE. The shortest average 
time for overall pain relief is achieved by a combination 
between polymyxin B sulfate and tyrothricin, which is on 
the 4.85th day. In contrast, the combination of butyl para-
aminobenzoate and iodoform takes 64.7 days, and ZOE 
takes 8.64 days. The comparison of the combination 
between butyl para-aminobenzoate and iodoform and 
ZOE is examined by two articles [17], [18] with the 
different results. One article [18] states that there is a 
significant difference in the pain reduction between the 
group of a combination of butyl para-aminobenzoate 
and iodoform and the group of ZOE. It can be seen 
based on the score of VAS in the group of combination 
butyl para-aminobenzoate and iodoform, which is lower 
than that of the ZOE group. Pain intensity decreases 
more rapidly in the group of combination between 
butyl para-aminobenzoate and iodoform compared to 
ZOE. The average time needed to relieve the whole 
pain is shorter in the group of a combination of butyl 
para-aminobenzoate and iodoform compared to the 
ZOE group. Other results are shown by other articles 
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[17] stating that the VAS score in the 30th min of the 
examination after medicament application, on the 7th 
day and the 10th day was significantly lower in the ZOE 
group compared to the group of combination between 
butyl para-aminobenzoate and iodoform.
The combination of butyl para-aminobenzoate 
and iodoform is proven to be better in relieving pain 
compared to low-power red laser and low-power infrared 
laser (the first 6th h and 12th h after the observation on 
the 1st day, and the 6th h after the observation on the 2nd 
day). However, on the 12th h after the observation on 
the 2nd day and the 3rd day, the VAS score is lower in the 
low-power red laser group compared to the group of the 
combination between butyl para-aminobenzoate and 
iodoform [19] groups. A similar result appears in another 
article [20], where the most drastic pain reduction is 
showed in the low-level laser therapy group, compared 
to the group of the combination between butyl para-
aminobenzoate and iodoform on the observation on 
the 3rd day and the 7th day. The highest pain intensity 
in dry socket appears between 48 and 72 h after the 
tooth extraction [18]. It can be concluded that low-
power red laser and low-level laser therapy are more 
effective in controlling pain as it produces significant 
pain remission ranging from the 2nd and the 3rd day after 
the tooth extraction.
Furthermore, another laser studied was a diode 
laser. The result showed that there was a significant 
difference in the pain reduction between the group of 
the combination between butyl para-aminobenzoate 
and iodoform and the group of diode laser on the 
observation on the 3rd, 4th, and 5th day in which the 
group of diode laser showed a better result.
On the other comparison, the combination of 
butyl para-aminobenzoate and iodoform is revealed 
to be better in reducing pain than the chlorhexidine 
digluconate gel [16], [17]. One of the articles [16] shows 
that there is a significant difference in pain reduction 
between the two groups, on the 2nd and the 4th day, 
where the combination of butyl para-aminobenzoate and 
iodoform is proven to be more effective in reducing pain. 
In the result of the research presented [17], it revealed 
that no research subject experienced severe pain 
starting from the 2nd day on the group of a combination 
of butyl para-aminobenzoate and iodoform. Meanwhile, 
in the group of chlorhexidine digluconate gel, there were 
still 64% of the study subjects experiencing severe pain 
on the 2nd day and 21.6% were on the 3rd day.
The different result appears in one article [14], 
which compared between the group of hyaluronic 
acid with or without aminocaproic and the group of 
the combination of butyl para-aminobenzoate and 
iodoform. On the 3rd, 4th, and 5th day of the examination, 
the pain reduction was shown better in hyaluronic 
acid than the group of the combination between butyl 
para-aminobenzoate and iodoform. This significant 
difference was statistically measured. The level of pain 
is almost similar between the group, which only received 
hyaluronic acid and the group which was additionally 
treated with aminocaproic acid.
Healing
As the indicators of the healing process vary, 
the comparison of the outcomes is relatively difficult 
to carry. The healing process of alveolar mucosa in 
the group of the combination between butyl para-
aminobenzoate and iodoform is shown to be better, 
both in the indicator of time required for covering the 
socket by granulation tissue and in the number of 
complications. A clinical indication of the healing used 
is the empty socket, open bone, and red marks around 
the socket [12], [13].
The group of the combination between 
polymyxin B sulfate, tyrothricin, neomycin sulfate, and 
tetracaine hydrochloride is proved to be better in wound 
healing compared to the group of the combination 
between butyl para-aminobenzoate and iodoform, both 
in the indicator of the empty socket, exposed bone, as 
well as the red marks around the socket [13].
The comparison between the group of the 
combination between butyl para-aminobenzoate 
and iodoform with freeze-dried pledget containing 
acemannan hydrogel, and the group of low-level laser 
therapy proves that the best healing process on the 3rd 
day was shown in the group of low-level laser therapy 
with the healing indicators such as the empty socket 
and red marks around the socket (all patients recovered 
from the empty sockets, and only 3% of them still 
experienced red marks around the socket). Meanwhile, 
in terms of the exposed bone, there are two groups 
with the best healing process, namely, the freeze-dried 
pledget group containing acemannan hydrogel where 
it showed 8.6% of patients recovering from the open 
bone, and the group of low-level laser therapy, where 
it showed that only 1% out of 12.5% of patients still 
experienced the open bone [20]. The recovery process 
of the open bone, inflammation reduction, and halitosis 
is significantly faster in PGRF group than in the group 
of the combination of butyl para-aminobenzoate and 
iodoform [18].
In another line, a different result appears in 
another article [14]. It reveals that the combination 
between butyl para-aminobenzoate and iodoform has 
slow action in reducing the swollen lymph node and 
redness around the gingiva and halitosis.
Conclusion
All articles reviewed identified pain reduction 
after treatment as an indicator of success. About this, 
four articles [6], [15], [16], [17] did not conduct a hearing 
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assessment. In terms of the average of time in pain 
reduction, the combination of butyl para-aminobenzoate 
and iodoform started to reduce the pain faster than the 
chlorhexidine digluconate gel and the combination 
between polymyxin B sulfate, tyrothricin, neomycin 
sulfate, and tetracaine hydrochloride. Furthermore, the 
combination of butyl para-aminobenzoate and iodoform 
is also better in pain reduction compared to low-power 
red laser and low-power infrared laser on the first 6th h 
and the 12th h of observation on the 1st day and on the 
first 6th h on the 2nd day.
Another result revealed that there was no 
difference in terms of pain reduction between the group 
of the combination between butyl para-aminobenzoate 
and iodoform, and the group of freeze-dried pledget 
containing acemannan hydrogel and the provision of 
Er:Cr:YSGG radiation. Pain reduction using hyaluronic 
acid, with or without aminocaproic acid, and diode laser 
on the observation of the 3rd, 4th, and 5th day showed a 
better result than the one with the combination between 
butyl para-aminobenzoate and iodoform. Meanwhile, 
the treatment using polymyxin B sulfate, tyrothricin, 
neomycin sulfate, and tetracaine hydrochloride needed 
shorter time to relieve the whole pain than the one 
using the combination of butyl para-aminobenzoate 
and iodoform.
In another line, the treatment using hyaluronic 
acid with or without aminocaproic acid, low-power red 
laser, and low-power infrared laser on the first 12 h 
observation on the 2nd and 3rd day, and the treatment 
using low-level laser therapy on the 3rd and 11th day 
observation showed a better result in pain control and 
healing process than the one using the combination 
between butyl para-aminobenzoate and iodoform.
Besides that, in terms of time indicators and 
complications, the result of the healing of alveolar 
mucosa was better in the group of the combination 
of butyl para-aminobenzoate and iodoform than a 
group of ZOE. The healing process of the socket with 
the treatment using polymyxin B sulfate, tyrothricin, 
neomycin sulfate, tetracaine hydrochloride, diode 
laser, PRGF, low-level laser therapy, and freeze-dried 
pledget containing acemannan hydrogel showed better 
results than the one using the combination between 
butyl para-aminobenzoate and iodoform. Besides, 
alveolar mucosal healing process with treatment using 
Er:Cr:YSGG laser showed a better result, but it did not 
show any significant differences compared to others.
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